Correlation Between Vertex Pharmaceuticals and DXC Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and DXC Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and DXC Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals and DXC Technology, you can compare the effects of market volatilities on Vertex Pharmaceuticals and DXC Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of DXC Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and DXC Technology.

Diversification Opportunities for Vertex Pharmaceuticals and DXC Technology

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Vertex and DXC is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and DXC Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DXC Technology and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with DXC Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DXC Technology has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and DXC Technology go up and down completely randomly.

Pair Corralation between Vertex Pharmaceuticals and DXC Technology

Assuming the 90 days trading horizon Vertex Pharmaceuticals is expected to generate 1.51 times more return on investment than DXC Technology. However, Vertex Pharmaceuticals is 1.51 times more volatile than DXC Technology. It trades about 0.07 of its potential returns per unit of risk. DXC Technology is currently generating about -0.07 per unit of risk. If you would invest  560,000  in Vertex Pharmaceuticals on September 13, 2024 and sell it today you would earn a total of  387,069  from holding Vertex Pharmaceuticals or generate 69.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vertex Pharmaceuticals  vs.  DXC Technology

 Performance 
       Timeline  
Vertex Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Vertex Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
DXC Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days DXC Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, DXC Technology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Vertex Pharmaceuticals and DXC Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vertex Pharmaceuticals and DXC Technology

The main advantage of trading using opposite Vertex Pharmaceuticals and DXC Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, DXC Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DXC Technology will offset losses from the drop in DXC Technology's long position.
The idea behind Vertex Pharmaceuticals and DXC Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity